Concord Biotech Ltd.
NSE: CONCORDBIO - Healthcare
₹601.80+0.77%
Close on 12 Nov 2026
Price, last 130 trading days
RSI (14)42Neutral zone
TrendDowntrendPrice vs 20 and 50 day averages
Volume196,4470.6x its 20-day average
MACD-21.33MACD below signal (momentum weak)
20-day average₹636.65Price is below it
50-day average₹685.81Price is below it
200-day average₹632.39Price is below it
20-day breakoutNoClosing at a 20-day high
52-week range
Low ₹493.50High ₹807.50
What this means in plain words
- The price is below its 20-day average, which is below its 50-day average. That pattern is usually described as a downtrend.
- RSI is 42. Readings above 70 are often called overbought and below 30 oversold, but strong stocks can stay in those zones for a while.
- The price is 25.5% below its 52-week high.
More in Healthcare
Abbott India Ltd.ABBOTINDIA
₹26,600.00+1.88%
Acutaas Chemicals Ltd.ACUTAAS
₹3,996.10+2.02%
Ajanta Pharmaceuticals Ltd.AJANTPHARM
₹3,324.00+0.13%
Anthem Biosciences Ltd.ANTHEM
₹938.45-1.99%
Apollo HospitalsAPOLLOHOSP
₹8,515.00-1.03%
Aster DM Quality Care Ltd.ASTERDM
₹735.90+1.62%
Biocon Ltd.BIOCON
₹370.95+0.79%
Caplin Point Laboratories Ltd.CAPLIPOINT
₹2,386.30-5.32%
Find similar ideas in the Screener All stocks
End-of-day data from a free public feed. It may be delayed or inaccurate. Technical indicators describe past price movement only. This page is for learning and is not investment advice or a recommendation to buy or sell.